Stock Price Quote

HEALTHCARE GLOBAL ENTERPRISES LTD.

NSE : HCGBSE : 539787ISIN CODE : INE075I01017Industry : Hospital & Healthcare ServicesHouse : HCG
BSE558.20-9.25 (-1.63 %)
PREV CLOSE ( ) 567.45
OPEN PRICE ( ) 583.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 44458
TODAY'S LOW / HIGH ( )547.55 583.90
52 WK LOW / HIGH ( )310.1 606.15
NSE558.70-6.85 (-1.21 %)
PREV CLOSE( ) 565.55
OPEN PRICE ( ) 567.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 558.70 (897)
VOLUME 255815
TODAY'S LOW / HIGH( ) 547.40 570.90
52 WK LOW / HIGH ( )330.65 601.95
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1998
Management Info
B S Ajai Kumar - Chairman - Managing Director
Registered Office

Address H C G Tower, No.8,P. Kalinga Rao Road,Sampangi Rama Nagar,
Bengaluru,
Karnataka-560027

Phone 080 - 33669999

Email info@hcgoncology.com

Website www.hcgoncology.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

16Apr Clarification sought from HealthCare
The Exchange has sought clarification from HealthCare Global Enterprises..
29Mar HealthCare Global Enterprises informs
HealthCare Global Enterprises has attached copies of newspaper advertise..
29Mar HealthCare Global Enterprises informs
Pursuant to SEBI PIT Regulations, SEBI LODR Regulations and Insider Trad..
19Mar HealthCare Global Enterprises informs
HealthCare Global Enterprises has informed that the Exchange has receive..
17Mar Announcement under Regulation 30 (LOD
Intimation under Regulation 30 and other applicable provisions of SEBI (..

Financials

in Millions
QTR Dec 24 ANNUAL 24
Net Profit-373.3339.600000000001
Gross Profit -363.8 548.600000000001
Operating Profit 476.12131.3
Net Sales 3125.111025.7

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr. Lal Pathlabs (BSE)
peergroup  2906.55 (4.26%)
M.Cap ( in Cr)24296.36
Thyrocare Tech. (BSE)
peergroup  903.80 (6.83%)
M.Cap ( in Cr)4789.55
Krishna Inst.Medi (BSE)
peergroup  674.05 (1.04%)
M.Cap ( in Cr)26971.36
Lotus Eye Hospital (BSE)
peergroup  72.80 (7.44%)
M.Cap ( in Cr)152.25
Krsnaa Diagnostics (BSE)
peergroup  764.30 (0.57%)
M.Cap ( in Cr)2467.91

Shareholding Pattern

MUTUAL FUNDS/UTI 9.19%
PROMOTERS 71.22%
NON-INSTITUTION 13.86%
FI/BANKS/INSURANCE 0.48%
GOVERNMENT 0%
FII 0%

About Healthcare Global Enterprises Ltd.

Healthcare Global Enterprises Ltd. was incorporated in the year 1998. Its today's share price is 558.2. Its current market capitalisation stands at Rs 7794.02 Cr. In the latest quarter, company has reported Gross Sales of Rs. 10992.9 Cr and Total Income of Rs.11161.69 Cr. The company's management includes Rajagopalan Raghavan, Anjali Rossi Ajaikumar, Rajiv Mailwal, Pradip Kanakia, Meghraj Arvindrao Gore, Geeta Mathur, Amit Soni, Siddharth Patel, B S Ajai Kumar, Sunu Manuel.

It is listed on the BSE with a BSE Code of 539787 , NSE with an NSE Symbol of HCG and ISIN of INE075I01017. It's Registered office is at H C G Tower, No.8,P. Kalinga Rao Road,Sampangi Rama NagarBengaluru-560027, Karnataka. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Co LLP, Deloitte Haskins & Sells, Deloittee Haskins & Sells

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.